{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:19:51Z","timestamp":1790198391435,"version":"4.1.0"},"reference-count":29,"publisher":"Japanese Society of Veterinary Science","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Veterinary Medical Science","J. Vet. Med. Sci."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1292\/jvms.14-0032","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T19:10:08Z","timestamp":1410808208000},"page":"1-6","source":"Crossref","is-referenced-by-count":32,"title":["Epidermal growth factor receptor expression in canine transitional cell carcinoma"],"prefix":"10.1292","volume":"77","author":[{"given":"Kiwamu","family":"HANAZONO","sequence":"first","affiliation":[{"name":"Department of Small Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai Midorimachi, Ebetsu-shi, Hokkaido 069\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"FUKUMOTO","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai Midorimachi, Ebetsu-shi, Hokkaido 069\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"KAWAMURA","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathology, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai Midorimachi, Ebetsu-shi, Hokkaido 069\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"ENDO","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai Midorimachi, Ebetsu-shi, Hokkaido 069\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"KADOSAWA","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai Midorimachi, Ebetsu-shi, Hokkaido 069\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetomo","family":"IWANO","sequence":"additional","affiliation":[{"name":"Department of Basic Veterinary Medicine, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai Midorimachi, Ebetsu-shi, Hokkaido 069\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"UCHIDE","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai Midorimachi, Ebetsu-shi, Hokkaido 069\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","unstructured":"1. Chow, N. H., Liu, H. S., Lee, E. I., Chang, C. J., Chan, S. H., Cheng, H. L., Tzai, T. S. and Lin, J. S. 1997. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. <i>Anticancer Res.<\/i> 17: 1293\u20131296."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. De Luca, A., Carotenuto, A., Rachiglio, A., Gallo, M., Maiello, M. R., Aldinucci, D., Pinto, A. and Normanno, N. 2008. The role of the EGFR signaling in tumor microenvironment. <i>J. Cell. Physiol.<\/i> 214: 559\u2013567.","DOI":"10.1002\/jcp.21260"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dhawan, D., Ramos-Vara, J. A., Stewart, J. C., Zheng, R. and Knapp, D. W. 2009. Canine invasive transitional cell carcinoma cell lines: <i>in vitro<\/i> tools to complement a relevant animal model of invasive urinary bladder cancer. <i>Urol. Oncol.<\/i> 27: 284\u2013292.","DOI":"10.1016\/j.urolonc.2008.02.015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dominguez-Escrig, J. L., Kelly, J. D., Neal, D. E., King, S. M. and Davies, B. R. 2004. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer. <i>Clin. Cancer Res.<\/i> 10: 4874\u20134884.","DOI":"10.1158\/1078-0432.CCR-04-0034"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. el-Marjou, A., Delouv\u00e9e, A., Thiery, J. P. and Radvanyi, F. 2000. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression. <i>Carcinogenesis<\/i> 21: 2211\u20132218.","DOI":"10.1093\/carcin\/21.12.2211"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gama, A., G\u00e4rtner, F., Alves, A. and Schmitt, F. 2009. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues. <i>Res. Vet. Sci.<\/i> 87: 432\u2013437.","DOI":"10.1016\/j.rvsc.2009.04.016"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hardy, K. M., Yatskievych, T. A., Konieczka, J., Bobbs, A. S. and Antin, P. B. 2011. FGF signalling through RAS\/MAPK and PI3K pathways regulates cell movement and gene expression in the chicken primitive streak without affecting E-cadherin expression. <i>BMC Dev. Biol.<\/i> 11: 20.","DOI":"10.1186\/1471-213X-11-20"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Henry, C. J. 2003. Management of transitional cell carcinoma. <i>Vet. Clin. North Am. Small Anim. Pract.<\/i> 33: 597\u2013613.","DOI":"10.1016\/S0195-5616(03)00032-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ikeda, S., Funakoshi, N. and Suzuki, K. 2009. Usefulness of epidermal growth factor receptor and p53 cocktail immunostaining for differential diagnosis with urine cytology. <i>Acta Cytol.<\/i> 53: 29\u201335.","DOI":"10.1159\/000325082"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Knapp, D. W., Glickman, N. W., Denicola, D. B., Bonney, P. L., Lin, T. L. and Glickman, L. T. 2000. Naturally-occurring canine transitional cell carcinoma of the urinary bladder. A relevant model of human invasive bladder cancer. <i>Urol. Oncol.<\/i> 5: 47\u201359.","DOI":"10.1016\/S1078-1439(99)00006-X"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Liang, K., Ang, K. K., Milas, L., Hunter, N. and Fan, Z. 2003. The epidermal growth factor receptor mediates radioresistance. <i>Int. J. Radiat. Oncol. Biol. Phys.<\/i> 57: 246\u2013254.","DOI":"10.1016\/S0360-3016(03)00511-X"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lipponen, P. and Eskelinen, M. 1994. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis. <i>Br. J. Cancer<\/i> 69: 1120\u20131125.","DOI":"10.1038\/bjc.1994.220"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Martinez, I., Mattoon, J. S., Eaton, K. A., Chew, D. J. and DiBartola, S. P. 2003. Polypoid cystitis in 17 dogs (1978\u20132001). <i>J. Vet. Intern. Med.<\/i> 17: 499\u2013509.","DOI":"10.1111\/j.1939-1676.2003.tb02471.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. McConkey, D. J., Choi, W., Marquis, L., Martin, F., Williams, M. B., Shah, J., Svatek, R., Das, A., Adam, L., Kamat, A., Siefker-Radtke, A. and Dinney, C. 2009. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. <i>Cancer Metastasis Rev.<\/i> 28: 335\u2013344.","DOI":"10.1007\/s10555-009-9194-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mellon, K., Wright, C., Kelly, P., Horne, C. H. and Neal, D. E. 1995. Long-term outcome related to epidermal growth factor receptor status in bladder cancer. <i>J. Urol.<\/i> 153: 919\u2013925.","DOI":"10.1016\/S0022-5347(01)67604-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Memon, A. A., Sorensen, B. S., Meldgaard, P., Fokdal, L., Thykjaer, T. and Nexo, E. 2006. The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients. <i>Br. J. Cancer<\/i> 94: 1703\u20131709.","DOI":"10.1038\/sj.bjc.6603154"},{"key":"17","unstructured":"17. Meuten, D. J., Everitt, J., Inskeep, W., Jacobs, R. M., Peleteiro, M. and Thompson, K. G. 2004. Urinary bladder tumors. pp. 26\u201337. <i>In<\/i>: WHO Histological Classification of Tumors of the Urinary Bladder System of Domestic Animals, 2nd ed. (Schulman, F. Y. ed.), Armed Forces Institute of Pathology, Washington, D.C."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Miyamoto, H., Kubota, Y., Noguchi, S., Takase, K., Matsuzaki, J., Moriyama, M., Takebayashi, S., Kitamura, H. and Hosaka, M. 2000. C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer. <i>Urology<\/i> 55: 679\u2013683.","DOI":"10.1016\/S0090-4295(99)00604-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mutsaers, A. J., Widmer, W. R. and Knapp, D. W. 2003. Canine transitional cell carcinoma. <i>J. Vet. Intern. Med.<\/i> 17: 136\u2013144.","DOI":"10.1111\/j.1939-1676.2003.tb02424.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Neal, D. E., Marsh, C., Bennett, M. K., Abel, P. D., Hall, R. R., Sainsbury, J. R. and Harris, A. L. 1985. Epidermal-growth factor receptors in human bladder cancer: comparison of invasive and superficial tumours. <i>Lancet<\/i> 1: 366\u2013368.","DOI":"10.1016\/S0140-6736(85)91386-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Norris, A. M., Laing, E. J., Valli, V. E., Withrow, S. J., Macy, D. W., Ogilvie, G. K., Tomlinson, J., McCaw, D., Pidgeon, G. and Jacobs, R. M. 1992. Canine bladder and urethral tumors: A retrospective study of 115 cases (1980\u20131985). <i>J. Vet. Intern. Med.<\/i> 6: 145\u2013153.","DOI":"10.1111\/j.1939-1676.1992.tb00330.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nutt, J. E., Mellon, J. K., Qureshi, K. and Lunec, J. 1998. Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in the urine of patients with bladder tumours. <i>Br. J. Cancer<\/i> 78: 215\u2013220.","DOI":"10.1038\/bjc.1998.467"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ono, M. and Kuwano, M. 2006. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. <i>Clin. Cancer Res.<\/i> 12: 7242\u20137251.","DOI":"10.1158\/1078-0432.CCR-06-0646"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Rowinsky, E. K. 2004. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. <i>Annu. Rev. Med.<\/i> 55: 433\u2013457.","DOI":"10.1146\/annurev.med.55.091902.104433"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Selvarajah, G. T., Verheije, M. H., Kik, M., Slob, A., Rottier, P. J., Mol, J. A. and Kirpensteijn, J. 2012. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis. <i>Vet. J.<\/i> 193: 412\u2013419.","DOI":"10.1016\/j.tvjl.2012.02.009"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Shiomitsu, K., Johnson, C. L., Malarkey, D. E., Pruitt, A. F. and Thrall, D. E. 2009. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours. <i>Vet. Comp. Oncol.<\/i> 7: 106\u2013114.","DOI":"10.1111\/j.1476-5829.2009.00178.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Th\u00f8gersen, V. B., J\u00f8rgensen, P. E., S\u00f8rensen, B. S., Bross, P., Orntoft, T., Wolf, H. and Nex\u00f8, E. 1999. Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer. <i>Scand. J. Clin. Lab. Invest.<\/i> 59: 267\u2013277.","DOI":"10.1080\/00365519950185634"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Wolff, A. C., Hammond, M. E., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Mitchell, D., Fitzgibbons, P. L., Hanna, W. M., Langer, A., McShane, L. M., Paik, S., Pegram, M. D., Perez, E. A., Press, M. F., Rhodes, A., Sturgeon, C., Taube, S. E., Tubbs, R., Vance, G. H., van de Vijver, M., Wheeler, T. M. and Hayes, D. F. 2007. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. <i>Arch. Pathol. Lab. Med.<\/i> 131: 18\u201343.","DOI":"10.1200\/JCO.2006.09.2775"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Wood, D. P. Jr., Fair, W. R. and Chaganti, R. S. 1992. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer. <i>J. Urol.<\/i> 147: 274\u2013277.","DOI":"10.1016\/S0022-5347(17)37212-9"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T20:37:20Z","timestamp":1565815040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/77\/1\/77_14-0032\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.14-0032","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}